Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.
Latest News
- ‘Worse than a recession’: Billionaire investor Ray Dalio sounds alarm on Trump’s economic agenda
- Oil Drops on Signs Conflict May Spare Iranian Crude Production
- Why Oil Stocks Are Being Left Behind in the Energy Rally
- 4 Ways to Find Winners in a Rising Market
- At Home closing? Bankruptcy puts dozens of stores at risk of shutting down
- U.S. Steel Stock Is Rising. Trump OKs Nippon Deal After Getting ‘Golden Share.’